Farmaceutica R (RMAH) — Tangible Net Worth Ratio
Farmaceutica R (RMAH) has a Tangible Net Worth Ratio of 98.3% as of June 2026. This metric is calculated by deducting intangible assets (RON1.24 Million) from net assets (RON73.50 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Farmaceutica R net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Farmaceutica R Tangible Net Worth Ratio (2020–2025)
This chart shows how Farmaceutica R's Tangible Net Worth Ratio has changed across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 98.3%, reflecting net assets of RON73.50 Million with intangible assets of RON1.24 Million RON.
Annual Tangible Net Worth Ratio for Farmaceutica R (2020–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Farmaceutica R from 2020 to 2025, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Farmaceutica R stock valuation.
| Year | Tangible NW Ratio | Net Assets (RON) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.2% | RON79.61 Million | RON1.45 Million | RON383.19 Million | ▼ -0.3 pp |
| 2024 | 98.5% | RON73.94 Million | RON1.10 Million | RON375.04 Million | ▲ +0.2 pp |
| 2023 | 98.3% | RON70.86 Million | RON1.18 Million | RON315.76 Million | ▼ -0.5 pp |
| 2022 | 98.8% | RON68.43 Million | RON798.25K | RON286.20 Million | ▼ 0.0 pp |
| 2021 | 98.9% | RON68.22 Million | RON767.97K | RON251.07 Million | ▼ -0.7 pp |
| 2020 | 99.6% | RON79.83 Million | RON338.43K | RON244.46 Million | — |